Plenty of "ifs" here, we already have two others with claimed cures for cancer (PRR and SBP) in the latter case, over 100 cancer types and not one of them has not responded.
Both are going down, overseas investors are simply not enthused about small spec biotechs is a market that is taking a bruising. Expect all 3 to climb if and when more advanced tests confirm success. Of course, all will have runs on gossip/anns/ramps in between.
Bomber
